R. Matsubara, A. Ando, Y. Saeki, K. Eda, N. Asada, T. Tsutsumi, Y. S. Shin, and M. Hayashi
Vol 000
(1H, septet, J = 6.8 Hz, CH), 7.55–7.69 (3H, m, Ar-H),
7.88–8.20 (4H, m, Ar-H); 2iB (distinguishable peak): 3.30
(1H, septet, J = 6.8 Hz, CH). 13C NMR [100 MHz, CDCl3/
TMS, δ (ppm)]: 2iA: 157.0, 132.8, 129.1, 128.5, 128.4,
127.9, 127.8, 124.6, 127.2, 124.6, 124.0, 118.7, 23.8,
17.1; 2iB (distinguishable peaks): 162.2, 133.7, 132.9,
129.1, 128.5, 127.9, 127.8, 127.1, 124.1, 23.8, 17.1. MS
(EI): m/z 254 (M+), 194 (M–N2O2). Anal. Calcd. for
C15H14N2O2: C, 70.85; H, 5.55; N, 11.02. Found: C,
70.97; H, 5.71; N, 10.91.
three times with Et2O. The combined organic layer was washed
with water and dried over Na2SO4. The residue obtained after
evaporation of the volatiles was purified by chromatography on
silica gel (EtOAc–hexane) to give furoxan 2m (115 mg, 49%)
as colorless oil. Rf 0.35 (hexane:EtOAc = 1:1). IR (neat), ν
(cmꢀ1): 1184, 1202, 1330, 1390, 1429, 1448, 1465, 1478,
1574, 1592, 1734, 2979. 1H NMR [400 MHz, CDCl3/TMS, δ
(ppm)]: 2mA: 1.29 (3H, t, J = 7.0 Hz, OCH2CH3), 4.35–4.40
(2H, q, J = 7.0 Hz, OCH2CH3), 7.49–7.59 (3H, m, Ar-H),
7.64–7.71 (2H, m, Ar-H); 2mB (distinguishable peak): 1.39
(3H, t, J = 7.0 Hz, OCH2CH3), 4.46 (2H, q, J = 7.0 Hz,
OCH2CH3). 13C NMR [100 MHz, CDCl3/TMS, δ (ppm)]: 2mA:
156.5, 156.1, 131.6, 129.0, 128.5, 126.0, 63.0, 13.8; 2mB
(distinguishable peaks): 128.6, 128.4, 62.6. MS (EI): m/z 234
(M), 174 (M–N2O2). Anal. Calcd. for C11H10N2O4: C, 56.41;
H, 4.30; N, 11.96. Found: C, 56.52; H, 4.29; N, 11.80.
4-Phenyl-3-[(tetrahydro-2H-pyran-2-yloxy)methyl]furoxan
(2jA) and 3-phenyl-4-[(tetrahydro-2H-pyran-2-yloxy)methyl]
furoxan (2jB).
The reaction of the olefin (trans only) for
0.5 h following the general procedure gave 2j (146 mg, 53%) as
colorless oil. Rf 0.35 (hexane:EtOAc = 10:1). IR (neat), ν
(cmꢀ1): 963, 1010, 1058, 1076, 1119, 1479, 1577, 1597, 2942.
1H NMR [400 MHz, CDCl3/TMS, δ (ppm)]: 2jA: 1.51–1.81
(6H, m, CH2CH2CH2CH2O), 3.52–3.57 (2H, m, OCH2CH2),
3.78–3.84 (1H, m, OCHO), 4.60 (1H, d, J = 12.8 Hz, Ar-CH2),
4.74 (1H, d, J = 12.8 Hz, Ar-CH2), 7.30–7.58 (3H, m, Ar-H),
7.83–7.94 (2H, m, Ar-H); 2jB (distinguishable peak): 7.94–7.96
(2H, m, Ar-H). 13C NMR NMR [100 MHz, CDCl3/TMS, δ
(ppm)]: 2jA: 157.1, 131.2, 129.2, 127.5, 126.5, 122.6, 112.9,
99.2, 62.3, 57.2, 30.2, 25.1, 18.9; 2jB (distinguishable peaks):
154.3, 130.9, 129.3, 127.9, 122.9, 98.3, 59.8. MS (EI): m/z 175
(M–OTHP). Anal. Calcd. for C14H16N2O4: C, 60.86; H, 5.84;
N, 10.14. Found: C, 61.00; H, 5.88; N, 9.76.
3-[(tert-Butyldimethylsilyloxy)methyl]-4-phenylfuroxan (2kA) and
4-[(tert-butyldimethylsilyloxy)methyl]-3-phenylfuroxan (2kB). The
reaction of the olefin (trans only) for 0.5 h following the general
procedure gave 2k (212 mg, 69%) as colorless oil. Rf 0.4 (hexane:
EtOAc = 10:1). IR (neat), ν (cmꢀ1): 1276, 1384, 1434, 1461, 1579,
1600, 2853, 2930, 2957. 1H NMR [400 MHz, CDCl3/TMS, δ
(ppm)]: 2kA: 0.14 (6H, s), 0.88 (9H, s), 4.72 (2H, s), 7.47–7.58
(3H, m, Ar-H), 7.91–7.94 (2H, m, Ar-H); 2kB (distinguishable
peak): 4.83 (2H, s). 13C NMR NMR [100 MHz, CDCl3/TMS, δ
(ppm)]: 2kA: 157.5, 131.5, 129.1, 127.8, 126.6, 114.2, 54.1, 25.6,
18.1, ꢀ5.3; 2kB (distinguishable peaks): 130.5, 129.0, 127.6, 57.1.
MS (EI): m/z 249 (M–tBu), 189 (M–tBu–N2O2). Anal. Calcd. for
C14H16N2O4: C, 58.79; H, 7.24; N, 9.14. Found: C, 58.70; H, 7.36;
N, 9.20.
4,5-Dihydronaphtho[1,2-c][1,2,5]oxadiazole 3-oxide (2lA). The
reaction of the olefin for 1 h following the general procedure
gave 2lA (103 mg, 58%) as white solid. mp 84.4–85.5°C. Rf
0.3 (hexane:EtOAc = 10:1). IR (neat), ν (cmꢀ1): 1350, 1434,
1535, 1587, 2861, 2959. 1H NMR [400 MHz, CDCl3/TMS, δ
(ppm)]: 2.95 (2H, t, J = 7.6 Hz, Ar-CH2CH2CN), 3.12 (2H, t,
J = 7.6 Hz, Ar-CH2CH2CN), 7.33–7.48 (3H, m, Ar-H),
7.98–8.00 (1H, dd, J = 1.2, 9.2 Hz, Ar-H). 13C NMR
[100 MHz, CDCl3/TMS, δ (ppm)]: 153.4, 136.9, 131.6, 129.1,
127.8, 124.3, 123.6, 111.3, 27.2, 18.0. MS (EI): m/z 188 (M+),
128 (M–N2O2). Anal. Calcd. for C10H8N2O2: C, 63.83; H,
4.29; N, 14.89. Found: C, 63.75, H; 4.30, N; 14.74.
3-tert-Butyl-4-naphthylfuroxan (2 nA) and 4-tert-butyl-3-
naphthylfuroxan (2nB).
The reaction of the olefin (cis/
trans = 80/20) for 48 h following the general procedure gave 2n
1
(31 mg, 23%) as white solid. Rf 0.42 (hexane:EtOAc = 10:1). H
NMR [400 MHz, CDCl3/TMS, δ (ppm)]: 2nB: 1.30 (9H, s,
CH3), 7.42 (1H, dd, J = 8.4, 1.6 Hz, Ar-CH2), 7.56–7.63 (2H, m,
Ar-H), 7.89–7.93 (3H, m, Ar-H), 8.0 (1H, d, J = 8.0 Hz, Ar-H);
2nA (distinguishable peak): 1.25 (9H, s, CH3), 7.47 (1H, dd,
J = 8.4, 1.6 Hz, Ar-H). 13C NMR [400 MHz, CDCl3/TMS, δ
(ppm)]: 2nB: 164.9, 134.0, 133.1, 129.5, 128.5, 128.1, 127.3,
126.5, 122.1, 116.7, 33.8, 28.6; 2nA (distinguishable peaks):
157.8, 133.9, 132.7, 129.8, 128.5, 128.1, 127.8, 127.3, 126.2,
31.9, 27.1. MS (EI): m/z 268 (M+), 208 (M–N2O2). Anal. Calcd.
for C16H16N2O2: C, 71.62; H, 6.01; N, 10.44. Found: C, 71.42;
H, 6.01; N, 10.75.
Crystals of 2nB suitable for X-ray diffraction analysis were
obtained by recrystallization from EtOAc–hexane using a vapor
diffusion method.
4-(2-Methylpheny)-3-pentylfuroxan (2oA) and 3-(2-methylpheny)-
4-pentylfuroxan (2oB). The reaction of the olefin (cis/trans = 74/
26) for 48h following the general procedure gave 2o (76 mg,
31%) as yellow oil. Rf 0.42 (hexane:EtOAc= 10:1). IR (neat), ν
(cmꢀ1): 1184, 1202, 1330, 1390, 1429, 1448, 1465, 1478, 1574,
1
1592, 1734, 2979. H NMR [400 MHz, CDCl3/TMS, δ (ppm)]:
2oA: 0.79–0.85 (3H, m, CH2CH2CH3), 1.14–1.27 (4H, m,
CH2CH2CH3), 1.46–1.59 (2H, m, Ar-CH2), 2.33 (3H, s, Ar-CH3),
2.48 (2H, t, J = 8.0 Hz, Ar-CH2), 7.19–7.47 (4H, m, Ar-H); 2oB
(distinguishable peak): 2.26 (3H, s, Ar-CH3), 2.58–2.64 (2H, m,
Ar-CH2). 13C NMR [100 MHz, CDCl3/TMS, δ (ppm)]: 2oA:
157.5 137.3, 131.0, 130.1, 129.4, 126.2, 116.1, 30.8, 24.5, 22.3,
21.8, 19.6, 13.6; 2oB (distinguishable peaks): 158.2, 138.9, 131.0,
129.5, 126.3, 125.8, 122.0, 25.9, 25.6, 21.9, 19.1, 13.6. MS (EI):
m/z 186 (M–N2O2). Anal. Calcd. for C14H18N2O2: C, 68.27; H,
7.37; N, 11.37. Found: C, 68.20; H, 7.52; N, 11.12.
4-(2,2-Dimethylphenyl)-3-pentylfuroxan (2pA) and 3-(2,2-
dimethylphenyl)-4-pentylfuroxan (2pB).
The reaction of the
olefin (cis/trans = 71/29) for 48 h following the general procedure
gave 2p (57 mg, 22%) as yellow oil. Rf 0.35 (hexane:EtOAc = 10:1).
1H NMR [400 MHz, CDCl3/TMS, δ (ppm)]: 2pB: 0.79–0.85 (3H,
m, CH3), 1.19–1.59 (6H, m, CH2CH2CH2), 2.17 (6H, s, Ar-CH3),
2.50 (2H, t, J= 8.0 Hz, Ar-CH2), 7.16 (2H, d, J=7.6Hz, Ar-H), 7.33
(1H, t, J=8.0Hz, Ar-H); 2pA (distinguishable peak): 2.36 (2H, t,
J= 8.0 Hz, Ar-CH2). 13C NMR [100 MHz, CDCl3/TMS, δ (ppm)]:
2pB: 158.5, 138.6, 131.0, 128.2, 121.5, 115.4, 30.9, 25.9, 25.8, 22.0,
Crystals suitable for X-ray diffraction analysis were obtained by re-
crystallization from EtOAc–hexane using a vapor diffusion method.
Ethyl 4-phenylfuroxan-3-carboxylate (2mA) and Ethyl
3-phenylfuroxan-4-carboxylate (2mB). To a stirred solution
of trans-ethyl cinnamate (176.2 mg, 1 mmol) and pyridine
(242 μl, 3 mmol) in CH2Cl2 (1.4 mL) was added NOBF4
(348.7 mg, 3 mmol) at 0°C. Stirring was continued at 0°C for
48 h, and then the solution, diluted with water, was extracted
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet